Christopher M. O’Connor
Duke University
10 Papers
12 Citations
Christopher M. O’Connor is an academic researcher from Duke University. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 7, co-authored 10 publications. Previous affiliations of Christopher M. O’Connor include Durham University.
Chat about Author
Papers
Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial
Joseph G. Rogers,Chetan B. Patel,Robert J. Mentz,Bradi B. Granger,Karen E. Steinhauser,Mona Fiuzat,Patricia A. Adams,Adam Speck,Kimberly S. Johnson,Arun Krishnamoorthy,Hongqiu Yang,Kevin J. Anstrom,Gwen C. Dodson,Donald H. Taylor,Jerry Kirchner,Daniel B. Mark,Christopher M. O’Connor,James A. Tulsky +17 more
TL;DR: An interdisciplinary palliative care intervention in advanced HF patients showed consistently greater benefits in quality of life, anxiety, depression, and spiritual well-being compared with UC alone.
535
Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction
Jasper Tromp,Mohsin A.F. Khan,Robert J. Mentz,Christopher M. O’Connor,Marco Metra,Howard C. Dittrich,Piotr Ponikowski,John R. Teerlink,Gad Cotter,Beth A. Davison,John G.F. Cleland,Michael M. Givertz,Daniel M. Bloomfield,Dirk J. van Veldhuisen,Hans L. Hillege,Adriaan A. Voors,Adriaan A. Voors,Peter van der Meer +17 more
TL;DR: Biomarker profiles in patients with acute HFrEF were mainly related to cardiac stretch and in HFpEF related to inflammation, and patients with HFmrEF showed an intermediate biomarker profile with biomarker interactions between both cardiac Stretch and inflammation markers.
104
Evaluation of platelets in heart failure: Is platelet activity related to etiology, functional class, or clinical outcomes? ☆ ☆☆ ★ ★★
Paul A. Gurbel,Wendy A. Gattis,Sergey F. Fuzaylov,Laura H. Gaulden,Vic Hasselblad,Victor L. Serebruany,Christopher M. O’Connor +6 more
TL;DR: Platelet activity is heightened in 22% of outpatients with stable heart failure symptoms and is not affected by antecedent aspirin therapy, and the degree of platelet activation is similar in ischemic and nonischemic patients with heart failure and not related to clinical disease severity.
44
Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS).
John G.F. Cleland,John G.F. Cleland,John R. Teerlink,Beth A. Davison,Ahmad Shoaib,Marco Metra,Stefanie Senger,Olga Milo,Gad Cotter,Robert C. Bourge,John D. Parker,Guillaume Jondeau,Henry Krum,Christopher M. O’Connor,Guillermo Torre-Amione,Dirk J. van Veldhuisen,John J.V. McMurray +16 more
TL;DR: This work aimed to investigate the added prognostic value of admission measurements of BNP and troponins in patients with acute heart failure.
32
Evaluation of platelets in heart failure: Is platelet activity related to etiology, functional class, or clinical outcomes?
Paul A. Gurbel,Wendy A. Gattis,Sergey F. Fuzaylov,Laura H. Gaulden,Vic Hasselblad,Victor L. Serebruany,Christopher M. O’Connor +6 more
TL;DR: Platelet activity is heightened in 22% of outpatients with stable heart failure symptoms and is not affected by antecedent aspirin therapy, and the degree of platelet activation is similar in ischemic and nonischemic patients with heart failure and was not related to clinical disease severity.
26